Marksans Pharma Ltd (MARKSANS):企業の財務・戦略的SWOT分析

◆英語タイトル:Marksans Pharma Ltd (MARKSANS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14891
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company manufactures non-sterile liquids, ointments and powder products. It offers solid oral dosage in form of tablets, hard gelatin capsule and soft gelatin capsules. Marksans Pharma offers products in the therapy areas of antibiotics, antidiabetic, anti-inflammatory, cardiovascular, gynaecology and pain management among others. The company’s research and development capabilities include dossier development, process optimization, chemical synthesis, formulation development, analytical development, and conducting stability studies. It operates sophisticated manufacturing plant in Goa. It markets products through a network of distributors in the US, the UK, Australia, New Zealand and Canada, among others. Marksans Pharma is headquartered in Mumbai, Maharashtra, India.

Marksans Pharma Ltd Key Recent Developments

Jan 24,2019: Marksans Pharma: Change in directorate
Dec 31,2018: Marksans Pharma announces Resignation of its Director
Mar 14,2018: Appointment of Mr. Digant Mahesh Parikh as Independent Director
Jan 02,2018: Marksans Pharma announces Change in Director

This comprehensive SWOT profile of Marksans Pharma Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Marksans Pharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Marksans Pharma Ltd – Key Information
Marksans Pharma Ltd – Overview
Marksans Pharma Ltd – Key Employees
Marksans Pharma Ltd – Key Employee Biographies
Marksans Pharma Ltd – Key Operational Heads
Marksans Pharma Ltd – Major Products and Services
Marksans Pharma Ltd – History
Marksans Pharma Ltd – Company Statement
Marksans Pharma Ltd – Locations And Subsidiaries
Marksans Pharma Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Marksans Pharma Ltd – Business Description
Marksans Pharma Ltd – Corporate Strategy
Marksans Pharma Ltd – SWOT Analysis
SWOT Analysis – Overview
Marksans Pharma Ltd – Strengths
Marksans Pharma Ltd – Weaknesses
Marksans Pharma Ltd – Opportunities
Marksans Pharma Ltd – Threats
Marksans Pharma Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Marksans Pharma Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Marksans Pharma Ltd, Key Information
Marksans Pharma Ltd, Key Ratios
Marksans Pharma Ltd, Share Data
Marksans Pharma Ltd, Major Products and Services
Marksans Pharma Ltd, History
Marksans Pharma Ltd, Key Employees
Marksans Pharma Ltd, Key Employee Biographies
Marksans Pharma Ltd, Key Operational Heads
Marksans Pharma Ltd, Other Locations
Marksans Pharma Ltd, Subsidiaries
Marksans Pharma Ltd, Key Manufacturing facilities
Marksans Pharma Ltd, Key Competitors
Marksans Pharma Ltd, SWOT Analysis
Marksans Pharma Ltd, Ratios based on current share price
Marksans Pharma Ltd, Annual Ratios
Marksans Pharma Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Marksans Pharma Ltd, Performance Chart
Marksans Pharma Ltd, Ratio Charts

★海外企業調査レポート[Marksans Pharma Ltd (MARKSANS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tulip Star Hotels Limited:企業の戦略・SWOT・財務分析
    Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Renova Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Renova Therapeutics Inc (Renova) is a drug development company that focuses on the development of peptide infusion therapies and gene therapy treatments for cardiovascular and metabolic diseases. The company’s pipeline products include RT-100, RT-200, RT-110, RT-400, RT-210 and RT-300. Its R …
  • AusGroup Ltd (5GJ):石油・ガス:M&Aディール及び事業提携情報
    Summary AusGroup Ltd (AusGroup) is a provider of project and asset services. The company operates through its subsidiaries, namely, MAS, AGC, and NT Port and Marine. Its major services include mechanical and piping, scaffolding, multidisciplinary maintenance services, fabrication & management, surfa …
  • PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PhoreMost Ltd (PhoreMost) is a drug discovery company that develops drugs for the treatment of cancer. The company's lead drug discovery program is based on a novel target, which tackles the undruggable cancer gene KRAS that affects various types of cancer. It develops Site-Seeker, a platfor …
  • CIGNA Corporation:戦略・SWOT・企業財務分析
    CIGNA Corporation - Strategy, SWOT and Corporate Finance Report Summary CIGNA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Woolworths Limited:戦略・SWOT・企業財務分析
    Woolworths Limited - Strategy, SWOT and Corporate Finance Report Summary Woolworths Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cardinal Health Inc (CAH):医療機器:M&Aディール及び事業提携情報
    Summary Cardinal Health Inc (Cardinal Health) is a company that provides integrated healthcare services and products. It distributes branded and generic drugs; and specialty medicines; over-the-counter healthcare and consumer products; medical equipment; surgical devices; and laboratory products. It …
  • Sentien Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sentien Biotechnologies Inc (Sentien) is a clinical stage biotechnology company that develops novel delivery approaches to cell therapy. The company’s lead product SBI-101 is used for the treatment of patients with severe acute kidney injury (AKI). Its Sentinel is designed to enable controll …
  • Fitbit Inc.:戦略・SWOT・企業財務分析
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Enel Generacion Peru SAA (EDEGELC1):企業の財務・戦略的SWOT分析
    Summary Enel Generacion Peru SAA (Enel Generacion) a subsidiary of Enel Americas SA, is a power generation company. It offers transmission and distribution of electricity. The company generates electricity through thermal and hydroelectric sources. It also carries out hydroelectric plant generation …
  • Genomic Health Inc (GHDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Sappi Limited:企業の戦略・SWOT・財務分析
    Sappi Limited - Strategy, SWOT and Corporate Finance Report Summary Sappi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hollingsworth & Vose Company:企業の戦略的SWOT分析
    Hollingsworth & Vose Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Greene King Plc
    Greene King Plc - Strategy, SWOT and Corporate Finance Report Summary Greene King Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Orchids Paper Products Co (TIS):企業の財務・戦略的SWOT分析
    Orchids Paper Products Co (TIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Superior Energy Services Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Superior Energy Services Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Superior Energy Services Inc (Superior Energy) is a provider of equipment and production services to the energy industry. It offers drilling, completion and production-related services to in …
  • Siccar Point Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Siccar Point Energy Ltd (Siccar Point) is an oil and gas company that offers exploration and development of energy fields. The company acquires, and targets both operated and non-operated opportunities. Its exploration areas include Schiehallion field, Rosebank field, Suilven field, Cambo fi …
  • Abbott Laboratories:企業の戦略・SWOT・財務情報
    Abbott Laboratories - Strategy, SWOT and Corporate Finance Report Summary Abbott Laboratories - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Stryker Corporation:企業の戦略・SWOT・財務情報
    Stryker Corporation - Strategy, SWOT and Corporate Finance Report Summary Stryker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆